| Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite GH Nancollas, R Tang, RJ Phipps, Z Henneman, S Gulde, W Wu, ... Bone 38 (5), 617-627, 2006 | 1109 | 2006 |
| Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio T Yang, P Martin, B Fogarty, A Brown, K Schurman, R Phipps, VP Yin, ... Pharmaceutical research 32, 2003-2014, 2015 | 938 | 2015 |
| Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy RGG Russell, Z Xia, JE Dunford, UDO Oppermann, A Kwaasi, PA Hulley, ... Annals of the New York Academy of Sciences 1117 (1), 209-257, 2007 | 525 | 2007 |
| Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or … MR Allen, K Iwata, R Phipps, DB Burr Bone 39 (4), 872-879, 2006 | 287 | 2006 |
| Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate SY Tang, MR Allen, R Phipps, DB Burr, D Vashishth Osteoporosis international 20, 887-894, 2009 | 239 | 2009 |
| Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases JE Dunford, MJ Rogers, FH Ebetino, RJ Phipps, FP Coxon Journal of bone and mineral research 21 (5), 684-694, 2006 | 238 | 2006 |
| Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three‐dimensional microcomputed tomography B Borah, TE Dufresne, PA Chmielewski, GJ Gross, MC Prenger, ... Journal of Bone and Mineral Research 17 (7), 1139-1147, 2002 | 198 | 2002 |
| Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography B Borah, TE Dufresne, EL Ritman, SM Jorgensen, S Liu, PA Chmielewski, ... Bone 39 (2), 345-352, 2006 | 160 | 2006 |
| The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover B Borah, EL Ritman, TE Dufresne, SM Jorgensen, S Liu, J Sacha, ... Bone 37 (1), 1-9, 2005 | 151 | 2005 |
| Differences between bisphosphonates in binding affinities for hydroxyapatite MA Lawson, Z Xia, BL Barnett, JT Triffitt, RJ Phipps, JE Dunford, ... Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2010 | 140 | 2010 |
| Bone material properties in trabecular bone from human iliac crest biopsies after 3‐and 5‐year treatment with risedronate E Durchschlag, EP Paschalis, R Zoehrer, P Roschger, P Fratzl, R Recker, ... Journal of bone and mineral research 21 (10), 1581-1590, 2006 | 139 | 2006 |
| Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia K Iwata, J Li, H Follet, RJ Phipps, DB Burr Bone 39 (5), 1053-1058, 2006 | 133 | 2006 |
| Effects of 3‐and 5‐year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women R Zoehrer, P Roschger, EP Paschalis, JG Hofstaetter, E Durchschlag, ... Journal of Bone and Mineral Research 21 (7), 1106-1112, 2006 | 131 | 2006 |
| Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral EP Paschalis, DN Tatakis, S Robins, P Fratzl, I Manjubala, R Zoehrer, ... Bone 49 (6), 1232-1241, 2011 | 130 | 2011 |
| Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity S Suri, J Mönkkönen, M Taskinen, J Pesonen, MA Blank, RJ Phipps, ... Bone 29 (4), 336-343, 2001 | 124 | 2001 |
| Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading H Follet, J Li, RJ Phipps, S Hui, K Condon, DB Burr Bone 40 (4), 1172-1177, 2007 | 119 | 2007 |
| MicroRNA‐10b regulates tumorigenesis in neurofibromatosis type 1 G Chai, N Liu, J Ma, H Li, JL Oblinger, AK Prahalad, M Gong, LS Chang, ... Cancer science 101 (9), 1997-2004, 2010 | 117 | 2010 |
| Risedronate reduces intracortical porosity in women with osteoporosis B Borah, T Dufresne, J Nurre, R Phipps, P Chmielewski, L Wagner, ... Journal of bone and mineral research 25 (1), 41-47, 2010 | 104 | 2010 |
| Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro ZJ Henneman, GH Nancollas, FH Ebetino, RGG Russell, RJ Phipps Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2008 | 100 | 2008 |
| Strontium ranelate does not stimulate bone formation in ovariectomized rats RK Fuchs, MR Allen, KW Condon, S Reinwald, LM Miller, D McClenathan, ... Osteoporosis International 19, 1331-1341, 2008 | 94 | 2008 |
